Moreover, further research should be conducted to clarify how GLB suppresses colorectal carcinogenesis through means other than NLRP3 inhibition, which may lead to the elucidation of important mechanisms of inflammation-related colorectal cancer development and progression. The gene discussed is NLRP3; the disease is colorectal cancer.